等待開盤 09-09 09:30:00 美东时间
+0.477
+0.63%
Fulcrum Therapeutics announced that its management will participate in two investor conferences in New York, September 4 and 9, 2025, featuring fireside chats and company presentations. The sessions will be webcast live with replays available on their Investor Relations page. Fulcrum specializes in developing small molecules for rare genetic diseases, with its lead program pociredir targeting sickle cell disease by increasing fetal hemoglobin. In...
08-26 12:00
AXIL Brands, Inc. ("AXIL," "we," "us," "our," or the "Company") (NYSE:AXIL), an emerging global consumer products company for AXIL® hearing protection and enhancement products and Reviv3® hair and skin care
2024-04-15 20:34